1,3-Dibenzyl-4,5-dimethylimidazol-1-ium

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 1,3-Dibenzyl-4,5-dimethylimidazol-1-ium
• 化学式: C19H21N2+
• 分子量: 277.4
• InChiKey: CIMUKIAYRHMSJF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  21
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.21
• 拓扑面积：
  8.8
• 氢给体数：
  0
• 氢受体数：
  0

文献信息

• IMIDAZOLE ALKALOIDS FROM LEPIDIUM MEYENII AND METHODS OF USAGE
  申请人：Pure World Botanicals, Inc.

  公开号：EP1536787A2

  公开（公告）日：2005-06-08
• EP1536787A4
  申请人：——

  公开号：EP1536787A4

  公开（公告）日：2009-02-25
• [EN] IMIDAZOLE ALKALOIDS FROM LEPIDIUM MEYENII AND METHODS OF USAGE<br/>[FR] ALCALOIDES IMIDAZOLE DE LEPIDIUM MEYENII ET TECHNIQUES D'UTILISATION
  申请人：PURE WORLD BOTAN INC

  公开号：WO2004016216A2

  公开（公告）日：2004-02-26

  The present invention relates to novel imidazole alkaloid compounds that have been isolated as a form of chloride salt from a root extract of Lepidium meyenii Walp, with the common name Maca, and identified below as 1,3-bis(phenylmethyl)-4,5-dimethyl-1H-imidazlium chloride and 1,3-bis(phenylmethay)-2,4,5-trimethyl-1H-imidazlium chloride, compounds (1) and (2) respectively. The present invention further relates to the use of these novel compounds (1) and (2) to treat proliferative diseases, such as but not limited to cancer.